Genprex Inc — Quarterly Cash Flow (NASDAQ:GNPX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics

Quarterly Annual

Total assets 3.91 M4.12 M6.01 M3.83 M3.56 M Total liabilities 2.24 M2.5 M2.14 M2.44 M2.79 M Total equity 1.66 M1.62 M3.87 M1.39 M767.81 K Total liabilities & shareholders' equities 3.91 M4.12 M6.01 M3.83 M3.56 M Total debt ————— Net debt —————

Nachrichten

Patentzulassungen in Japan und Europa beflügeln Genprex-Aktie

Genprex stock jumps on Japan, Europe patent approvals

Genprex sichert sich Patente für Krebstherapie in Japan und Europa/n

Genprex receives Japanese and European patents for cancer therapy

Genprex receives patent approval in Australia for cancer therapy

Genprex reports positive data for diabetes gene therapy in animal studies

Genprex reports potential compliance with Nasdaq equity listing rule

Genprex reports phase 1 data for lung cancer gene therapy

Genprex reicht Prospektnachtrag für At-the-Market-Offering über bis zu 75 Mio. US-Dollar ein

Genprex receives US patent for cancer therapy combination

Genprex erhält europäisches Patent für kombinierte Krebs-Gentherapie

Genprex to receive European patent for cancer gene therapy combination